ProQR Therapeutics Statistics

Total Valuation

PRQR has a market cap or net worth of $158.40 million. The enterprise value is $51.98 million.

Market Cap	158.40M
Enterprise Value	51.98M

Important Dates

The next estimated earnings date is Tuesday, May 14, 2024, before market open.

Earnings Date	May 14, 2024
Ex-Dividend Date	n/a

Share Statistics

PRQR has 80.82 million shares outstanding.

Shares Outstanding	80.82M
Owned by Insiders (%)	18.87%
Owned by Institutions (%)	40.33%
Float	57.49M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	14.97
Forward PS	10.67
PB Ratio	3.57
P/FCF Ratio	5.24
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	4.91
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	1.72

Financial Position

The company has a current ratio of 3.54, with a Debt / Equity ratio of 0.48.

Current Ratio	3.54
Quick Ratio	3.52
Debt / Equity	0.48
Debt / EBITDA	n/a
Debt / FCF	0.70
Interest Coverage	-18.34

Financial Efficiency

Return on equity (ROE) is -56.70% and return on invested capital (ROIC) is -52.12%.

Return on Equity (ROE)	-56.70%
Return on Assets (ROA)	-19.20%
Return on Capital (ROIC)	-52.12%
Revenue Per Employee	$67,842
Profits Per Employee	-$200,278
Employee Count	156
Asset Turnover	0.07
Inventory Turnover	n/a

Taxes

Income Tax	-83,688
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -11.71% in the last 52 weeks. The beta is 0.25, so PRQR's price volatility has been lower than the market average.

Beta (1Y)	0.25
52-Week Price Change	-11.71%
50-Day Moving Average	2.13
200-Day Moving Average	1.78
Relative Strength Index (RSI)	41.67
Average Volume (30 Days)	206,825

Short Selling Information

Short Interest	241,523
Short Previous Month	261,073
Short % of Shares Out	0.42%
Short % of Float	n/a
Short Ratio (days to cover)	1.40

Income Statement

In the last 12 months, PRQR had revenue of $10.58 million and -$31.24 million in losses. Loss per share was -$0.38.

Revenue	10.58M
Gross Profit	10.22M
Operating Income	-34.18M
Pretax Income	-30.25M
Net Income	-31.24M
EBITDA	-25.99M
EBIT	-28.69M
Loss Per Share	-$0.38

Full Income Statement

Balance Sheet

The company has $127.60 million in cash and $21.17 million in debt, giving a net cash position of $106.42 million or $1.32 per share.

Cash & Cash Equivalents	127.60M
Total Debt	21.17M
Net Cash	106.42M
Net Cash Per Share	$1.32
Equity / Book Value	44.41M
Book Value Per Share	0.55
Working Capital	93.11M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $23.12 million and capital expenditures $7.11 million, giving a free cash flow of $30.23 million.

Operating Cash Flow	23.12M
Capital Expenditures	7.11M
Free Cash Flow	30.23M
FCF Per Share	$0.37

Full Cash Flow Statement

Margins

Gross margin is 96.56%, with operating and profit margins of -322.98% and -295.21%.

Gross Margin	96.56%
Operating Margin	-322.98%
Pretax Margin	-285.86%
Profit Margin	-295.21%
EBITDA Margin	-245.60%
EBIT Margin	-271.08%
FCF Margin	285.65%

Dividends & Yields

PRQR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.08%
Shareholder Yield	-13.08%
Earnings Yield	-19.72%
FCF Yield	19.09%

Analyst Forecast

The average price target for PRQR is $4.00, which is 104.08% higher than the current price. The consensus rating is "Buy".

Price Target	$4.00
Price Target Difference	104.08%
Analyst Consensus	Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	31.53%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

PRQR has an Altman Z-Score of -2.97 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.97
Piotroski F-Score	4